Institutional Experience With Robotic Lobectomy After Neoadjuvant Immunotherapy and Chemotherapy

Institutional Experience With Robotic Lobectomy After Neoadjuvant Immunotherapy and Chemotherapy

Background: The real-world safety of robotic resections after neoadjuvant chemoimmunotherapy remains poorly defined in patients with non-small cell lung cancer. Due to reported increased operative challenges after neoadjuvant immunotherapy, we aim to describe our early institutional experience and o...

Full description

Bibliographic Details
Main Authors: Shale J. Mack, BS, Hamza Rshaidat, MD, Annie Ho, BS, Brian M. Till, MD, Micaela L. Collins, MD, MPH, Gregory L. Whitehorn, BS, Jonathan Martin, BS, John D. Jacob, MD, Tyler R. Grenda, MD, Nathaniel R. Evans, III, MD, Olugbenga T. Okusanya, MD
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Annals of Thoracic Surgery Short Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2772993124001116

Internet

http://www.sciencedirect.com/science/article/pii/S2772993124001116

Similar Items